The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding



Mycroft-West, Courtney, Su, Dunhao ORCID: 0000-0002-9760-3419, Elli, Stefano ORCID: 0000-0003-0686-2480, Li, Yong ORCID: 0000-0002-5594-4434, Guimond, Scott ORCID: 0000-0002-5903-418X, Miller, Gavin ORCID: 0000-0001-6533-3306, Turnbull, Jeremy ORCID: 0000-0002-1791-754X, Yates, Edwin ORCID: 0000-0001-9365-5433, Guerrini, Marco, Fernig, David ORCID: 0000-0003-4875-4293
et al (show 2 more authors) (2020) The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding 2020.02.29.971093-. ISSN 2692-8205

[thumbnail of Heparin SARS2 bioRxiv.pdf] Text
Heparin SARS2 bioRxiv.pdf - Submitted version

Download (390kB) | Preview

Abstract

Many pathogens take advantage of the dependence of the host on the interaction of hundreds of extracellular proteins with the glycosaminoglycans heparan sulphate to regulate homeostasis and use heparan sulphate as a means to adhere and gain access to cells. Moreover, mucosal epithelia such as that of the respiratory tract are protected by a layer of mucin polysaccharides, which are usually sulphated. Consequently, the polydisperse, natural products of heparan sulphate and the allied polysaccharide, heparin have been found to be involved and prevent infection by a range of viruses including S-associated coronavirus strain HSR1. Here we use surface plasmon resonance and circular dichroism to measure the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin. The data demonstrate an interaction between the recombinant surface receptor binding domain and the polysaccharide. This has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals.

Item Type: Article
Uncontrolled Keywords: 3101 Biochemistry and Cell Biology, 31 Biological Sciences, Biodefense, Lung, Coronaviruses, Infectious Diseases, Emerging Infectious Diseases, Infection
Depositing User: Symplectic Admin
Date Deposited: 16 Apr 2020 13:19
Last Modified: 15 Jan 2026 18:01
DOI: 10.1101/2020.02.29.971093
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3083374
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.